Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W C Eckelman

Showing results (1-10 of 181) with videos related to

Pageof 19
Sort By:
European Journal of Nuclear Medicine|March 1, 1995
Radiolabeling with technetium-99m to study high-capacity and low-capacity biochemical systemsW C Eckelman
Nuclear Medicine and Biology|July 1, 1994
The application of receptor theory to receptor-binding and enzyme-binding oncologic radiopharmaceuticalsW C Eckelman
Nuclear Medicine and Biology|August 23, 2001
Radiolabeled muscarinic radioligands for in vivo studiesW C Eckelman
Nuclear Medicine and Biology|June 10, 1998
Sensitivity of new radiopharmaceuticalsW C Eckelman
Seminars in Nuclear Medicine|January 1, 1975
Technical considerations in labeling of blood elementsW C Eckelman
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1976
Letter: Chemical state of technetium in vivoW C Eckelman
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1995
Designing a molecular probe for muscarinic acetylcholine receptor (mAChR) imagingW C Eckelman
Cancer Research|February 1, 1990
Development of radiochemically pure antibodiesW C Eckelman
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
The status of radiopharmaceutical researchW C Eckelman
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
The use of in vitro models to predict the distribution of receptor binding radiotracers in vivoW C Eckelman
Pageof 19

Showing results (1-10 of 181) with videos related to

Sort By:
Pageof 19
European Journal of Nuclear Medicine|March 1, 1995
Radiolabeling with technetium-99m to study high-capacity and low-capacity biochemical systemsW C Eckelman
Nuclear Medicine and Biology|July 1, 1994
The application of receptor theory to receptor-binding and enzyme-binding oncologic radiopharmaceuticalsW C Eckelman
Nuclear Medicine and Biology|August 23, 2001
Radiolabeled muscarinic radioligands for in vivo studiesW C Eckelman
Nuclear Medicine and Biology|June 10, 1998
Sensitivity of new radiopharmaceuticalsW C Eckelman
Seminars in Nuclear Medicine|January 1, 1975
Technical considerations in labeling of blood elementsW C Eckelman
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1976
Letter: Chemical state of technetium in vivoW C Eckelman
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1995
Designing a molecular probe for muscarinic acetylcholine receptor (mAChR) imagingW C Eckelman
Cancer Research|February 1, 1990
Development of radiochemically pure antibodiesW C Eckelman
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
The status of radiopharmaceutical researchW C Eckelman
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
The use of in vitro models to predict the distribution of receptor binding radiotracers in vivoW C Eckelman
Pageof 19